oral vs subcutaneous semaglutide Change in body weight with active comparators at oral semaglutide vs subcutaneous semaglutide
Description
Portion Control and Appetite Suppression on GLP-1 Most semaglutide patients report that typical pre-treatment portion sizes feel uncomfortably large within 12 weeks of starting therapy
Nausea is the most frequently reported side effect for individuals starting GLP-1 medications
No emotional connection

Hypoglycaemia (low blood glucose) is uncommon when Ozempic is used as monotherapy, as its glucose-lowering effect is glucose-dependent
These medications do not directly target thyroid tissue or cause nodule formation

Who Might Benefit Most from Semaglutide
